Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer

The safety of oncolytic adenovirus-mediated suicide and interleukin-12 (IL12) gene therapy was evaluated in metastatic pancreatic cancer patients. In this phase I study, a replication-competent adenovirus (Ad5-yCD/mutTK(SR39)rep-hIL-12) expressing yCD/mutTK(SR39) (yeast cytidine deaminase/mutant S39...

Descripción completa

Detalles Bibliográficos
Autores principales: Barton, Kenneth N., Siddiqui, Farzan, Pompa, Robert, Freytag, Svend O., Khan, Gazala, Dobrosotskaya, Irina, Ajlouni, Munther, Zhang, Yingshu, Cheng, Jingfang, Movsas, Benjamin, Kwon, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851493/
https://www.ncbi.nlm.nih.gov/pubmed/33575474
http://dx.doi.org/10.1016/j.omto.2020.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851493/
https://www.ncbi.nlm.nih.gov/pubmed/33575474
http://dx.doi.org/10.1016/j.omto.2020.11.006

Ejemplares similares